Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1985 May;75(5):1671–1678. doi: 10.1172/JCI111875

Use of a murine monoclonal antibody for detection of circulating plasma DF3 antigen levels in breast cancer patients.

D F Hayes, H Sekine, T Ohno, M Abe, K Keefe, D W Kufe
PMCID: PMC425510  PMID: 3889057

Abstract

The murine monoclonal antibody (MAb), designated DF3, reacts with a 300,000-mol wt mammary epithelial antigen. A sequential double-determinant radioimmunoassay (RIA) has been developed to monitor circulating DF3 antigen. Using this assay, we have demonstrated that 33 of 36 normal women had plasma RIA antigen levels less than 150 U/ml. In contrast, 33 of 43 patients (76%) with metastatic breast cancer had RIA DF3 antigen levels greater than or equal to 150 U/ml. The difference between these two groups was statistically significant (P less than 0.001). Similar results have been obtained with a double-determinant enzyme-linked immunoassay (EIA). Only 6 of 111 age-matched normal subjects had EIA DF3 antigens levels greater than or equal to 30 U/ml, while 42 of 58 patients (72%) with breast cancer had levels equal to or above this value. Thus, similar patterns of specificity are obtained with the EIA or RIA. The elevation of circulating DF3 antigen levels in breast cancer patients has been confirmed by transfer blot assays. MAb DF3 reactivity occurred predominantly with circulating antigens of three different molecular weights ranging from 300,000 to approximately 400,000 mol wt. We also demonstrate that patients with both primary and metastatic breast cancer who were free of detectable disease at the time of sampling have DF3 antigen levels that are similar to those obtained from normal subjects. While patients with hepatoma (27%) and ovarian carcinoma (47%) also had elevated circulating DF3 antigen levels, the results suggest that DF3 antigen levels may be useful in distinguishing breast cancer patients from those with esophageal, gastric, colorectal, pancreatic, and lung carcinomas. Furthermore, the results of the RIA, EIA, and transblot analyses demonstrate that the measurement of circulating DF3 antigen levels provides a new and potentially useful marker to follow the clinical course of patients with metastatic breast cancer.

Full text

PDF
1671

Images in this article

1672Image
on p.1672
1674Image
on p.1674
1674Image
on p.1674

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abe M., Kufe D. W. Sodium butyrate induction of milk-related antigens in human MCF-7 breast carcinoma cells. Cancer Res. 1984 Oct;44(10):4574–4577. [PubMed] [Google Scholar]
  2. Arklie J., Taylor-Papadimitrious J., Bodmer W., Egan M., Millis R. Differentiation antigens expressed by epithelial cells in the lactating breast are also detectable in breast cancers. Int J Cancer. 1981 Jul 15;28(1):23–29. doi: 10.1002/ijc.2910280105. [DOI] [PubMed] [Google Scholar]
  3. Ceriani R. L., Peterson J. A., Lee J. Y., Moncada R., Blank E. W. Characterization of cell surface antigens of human mammary epithelial cells with monoclonal antibodies prepared against human milk fat globule. Somatic Cell Genet. 1983 Jul;9(4):415–427. doi: 10.1007/BF01543043. [DOI] [PubMed] [Google Scholar]
  4. Ceriani R. L., Sasaki M., Sussman H., Wara W. M., Blank E. W. Circulating human mammary epithelial antigens in breast cancer. Proc Natl Acad Sci U S A. 1982 Sep;79(17):5420–5424. doi: 10.1073/pnas.79.17.5420. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Colcher D., Hand P. H., Nuti M., Schlom J. A spectrum of monoclonal antibodies reactive with human mammary tumor cells. Proc Natl Acad Sci U S A. 1981 May;78(5):3199–3203. doi: 10.1073/pnas.78.5.3199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Croghan G. A., Papsidero L. D., Valenzuela L. A., Nemoto T., Penetrante R., Chu T. M. Tissue distribution of an epithelial and tumor-associated antigen recognized by monoclonal antibody F36/22. Cancer Res. 1983 Oct;43(10):4980–4988. [PubMed] [Google Scholar]
  7. Dao T. L., Ip C., Patel J. Serum sialyltransferase and 5'-nucleotidase as reliable biomarkers in women with breast cancer. J Natl Cancer Inst. 1980 Sep;65(3):529–534. [PubMed] [Google Scholar]
  8. Epenetos A. A., Canti G., Taylor-Papadimitriou J., Curling M., Bodmer W. F. Use of two epithelium-specific monoclonal antibodies for diagnosis of malignancy in serous effusions. Lancet. 1982 Nov 6;2(8306):1004–1006. doi: 10.1016/s0140-6736(82)90047-2. [DOI] [PubMed] [Google Scholar]
  9. Foster C. S., Edwards P. A., Dinsdale E. A., Neville A. M. Monoclonal antibodies to the human mammary gland. I. Distribution of determinants in non-neoplastic mammary and extra mammary tissues. Virchows Arch A Pathol Anat Histol. 1982;394(3):279–293. doi: 10.1007/BF00430671. [DOI] [PubMed] [Google Scholar]
  10. Franchimont P., Zangerle P. F., Hendrick J. C., Reuter A., Colin C. Simultaneous assays of cancer associated antigens in benign and malignant breast diseases. Cancer. 1977 Jun;39(6 Suppl):2806–2812. doi: 10.1002/1097-0142(197706)39:6<2806::aid-cncr2820390668>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  11. Gatter K. C., Abdulaziz Z., Beverley P., Corvalan J. R., Ford C., Lane E. B., Mota M., Nash J. R., Pulford K., Stein H. Use of monoclonal antibodies for the histopathological diagnosis of human malignancy. J Clin Pathol. 1982 Nov;35(11):1253–1267. doi: 10.1136/jcp.35.11.1253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Haagensen D. E., Jr, Kister S. J., Panick J., Giannola J., Hansen H. J., Wells S. A., Jr Comparative evaluation of carcinoembryonic antigen and gross cystic disease fluid protein as plasma markers for human breast carcinoma. Cancer. 1978 Sep;42(3 Suppl):1646–1652. doi: 10.1002/1097-0142(197809)42:3+<1646::aid-cncr2820420844>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  13. Hortobagyi G. N., Smith T. L., Legha S. S., Swenerton K. D., Gehan E. A., Yap H. Y., Buzdar A. U., Blumenschein G. R. Multivariate analysis of prognostic factors in metastatic breast cancer. J Clin Oncol. 1983 Dec;1(12):776–786. doi: 10.1200/JCO.1983.1.12.776. [DOI] [PubMed] [Google Scholar]
  14. Kleinberg D. L. Human alpha-lactalbumin: measurement in serum and in breast cancer organ cultures by radioimmunoassay. Science. 1975 Oct 17;190(4211):276–278. doi: 10.1126/science.1179206. [DOI] [PubMed] [Google Scholar]
  15. Kloppel T. M., Keenan T. W., Freeman M. J., Morré D. J. Glycolipid-bound sialic acid in serum: increased levels in mice and humans bearing mammary carcinomas. Proc Natl Acad Sci U S A. 1977 Jul;74(7):3011–3013. doi: 10.1073/pnas.74.7.3011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kufe D., Inghirami G., Abe M., Hayes D., Justi-Wheeler H., Schlom J. Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors. Hybridoma. 1984 Fall;3(3):223–232. doi: 10.1089/hyb.1984.3.223. [DOI] [PubMed] [Google Scholar]
  17. Leder A., Leder P. Butyric acid, a potent inducer of erythroid differentiation in cultured erythroleukemic cells. Cell. 1975 Jul;5(3):319–322. doi: 10.1016/0092-8674(75)90107-5. [DOI] [PubMed] [Google Scholar]
  18. Markwell M. A., Fox C. F. Surface-specific iodination of membrane proteins of viruses and eucaryotic cells using 1,3,4,6-tetrachloro-3alpha,6alpha-diphenylglycoluril. Biochemistry. 1978 Oct 31;17(22):4807–4817. doi: 10.1021/bi00615a031. [DOI] [PubMed] [Google Scholar]
  19. Mènard S., Tagliabue E., Canevari S., Fossati G., Colnaghi M. I. Generation of monoclonal antibodies reacting with normal and cancer cells of human breast. Cancer Res. 1983 Mar;43(3):1295–1300. [PubMed] [Google Scholar]
  20. Nakane P. K., Kawaoi A. Peroxidase-labeled antibody. A new method of conjugation. J Histochem Cytochem. 1974 Dec;22(12):1084–1091. doi: 10.1177/22.12.1084. [DOI] [PubMed] [Google Scholar]
  21. Nash C. H., 3rd, Jones S. E., Moon T. E., Davis S. L., Salmon S. E. Prediction of outcome in metastatic breast cancer treated with adriamycin combination chemotherapy. Cancer. 1980 Dec 1;46(11):2380–2388. doi: 10.1002/1097-0142(19801201)46:11<2380::aid-cncr2820461113>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  22. Papsidero L. D., Croghan G. A., O'Connell M. J., Valenzuela L. A., Nemoto T., Chu T. M. Monoclonal antibodies (F36/22 and M7/105) to human breast carcinoma. Cancer Res. 1983 Apr;43(4):1741–1747. [PubMed] [Google Scholar]
  23. Papsidero L. D., Nemoto T., Croghan G. A., Chu T. M. Expression of ductal carcinoma antigen in breast cancer sera as defined using monoclonal antibody F36/22. Cancer Res. 1984 Oct;44(10):4653–4657. [PubMed] [Google Scholar]
  24. Skipski V. P., Barclay M., Archibald F. M., Lynch T. P., Jr, Stock C. C. A new proteolipid apparently associated with cancer. Proc Soc Exp Biol Med. 1971 Apr;136(4):1261–1264. doi: 10.3181/00379727-136-35471. [DOI] [PubMed] [Google Scholar]
  25. Sloane J. P., Ormerod M. G. Distribution of epithelial membrane antigen in normal and neoplastic tissues and it value in diagnostic tumor pathology. Cancer. 1981 Apr 1;47(7):1786–1795. doi: 10.1002/1097-0142(19810401)47:7<1786::aid-cncr2820470711>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  26. Swenerton K. D., Legha S. S., Smith T., Hortobagyi G. N., Gehan E. A., Yap H. Y., Gutterman J. U., Blumenschein G. R. Prognostic factors in metastatic breast cancer treated with combination chemotherapy. Cancer Res. 1979 May;39(5):1552–1562. [PubMed] [Google Scholar]
  27. Taylor-Papadimitriou J., Peterson J. A., Arklie J., Burchell J., Ceriani R. L., Bodmer W. F. Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: production and reaction with cells in culture. Int J Cancer. 1981 Jul 15;28(1):17–21. doi: 10.1002/ijc.2910280104. [DOI] [PubMed] [Google Scholar]
  28. Thompson C. H., Jones S. L., Whitehead R. H., McKenzie I. F. A human breast tissue-associated antigen detected by a monoclonal antibody. J Natl Cancer Inst. 1983 Mar;70(3):409–419. [PubMed] [Google Scholar]
  29. To A., Coleman D. V., Dearnaley D. P., Ormerod M. G., Steele K., Neville A. M. Use of antisera to epithelial membrane antigen for the cytodiagnosis of malignancy in serous effusions. J Clin Pathol. 1981 Dec;34(12):1326–1332. doi: 10.1136/jcp.34.12.1326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Tormey D. C., Waalkes T. P. Clinical correlation between CEA and breast cancer. Cancer. 1978 Sep;42(3 Suppl):1507–1511. doi: 10.1002/1097-0142(197809)42:3+<1507::aid-cncr2820420823>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES